Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival

Blood (2019) 134 (Supplement_1): 855.

https://doi.org/10.1182/blood-2019-126674

Published: 2019

Journal Articles

Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease

Blood (2018) 132 (Supplement 1): 4455.

https://doi.org/10.1182/blood-2018-99-117021

Published: 2018

Journal Articles

Soluble CX3CL1/Fractalkine Is a New Player in the Pro-Inflammatory Microenvironment of Multiple Myeloma Patients Related to Bone Marrow Plasma Cell Infiltration and Neo-Vascularization

Anna Corcione, Valentina Marchica, Elisa Ferretti, Denise Toscani, PhD, Marina Bolzoni, PhD, Federica Costa, PhD, Cristina Mancini, MD, Eugenia Martella, MD, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Domenico Ribatti, MD, Angelo Vacca, MD PhD, Franco Aversa, MD, Vito Pistoia, MD, Nicola Giuliani, MD PhD

Blood (2017) 130 (Supplement 1): 3044.

https://doi.org/10.1182/blood.V130.Suppl_1.3044.3044

Published: 2017

Journal Articles

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells

Claudia Cocco, Sara Canale, Chiara Frasson, Emma Di Carlo, Emanuela Ognio, Domenico Ribatti, Ignazia Prigione, Giuseppe Basso, Irma Airoldi

Blood (2010) 116 (19): 3887–3898.

https://doi.org/10.1182/blood-2009-10-248245

Published: 2010

Journal Articles

HOXB7 Is Critically Involved in Multiple Myeloma-Induced Angiogenic Switch.

Paola Storti, Gaetano Donofrio, Marina Bolzoni, Simona Colla, Irma Airoldi, Valentina Sgobba, Manuela Abeltino, Katia Todoerti, Luca Agnelli, Mirca Lazzaretti, Cristina Mancini, Sabrina Bonomini, Domenico Ribatti, Vito Pistoia, Antonino Neri, Vittorio Rizzoli, Nicola Giuliani

Blood (2009) 114 (22): 125.

https://doi.org/10.1182/blood.V114.22.125.125

Published: 2009

Journal Articles

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

Aldo M. Roccaro, Antonio Sacco, Brian Thompson, Xavier Leleu, Abdel Kareem Azab, Feda Azab, Judith Runnels, Xiaoying Jia, Hai T. Ngo, Molly R. Melhem, Charles P. Lin, Domenico Ribatti, Barrett J. Rollins, Thomas E. Witzig, Kenneth C. Anderson, Irene M. Ghobrial

Blood (2009) 113 (26): 6669–6680.

https://doi.org/10.1182/blood-2009-01-198408

Published: 2009

Includes: Supplemental data

Journal Articles

Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib

Addolorata Maria Luce Coluccia, Teresa Cirulli, Paola Neri, Domenica Mangieri, Maria Cristina Colanardi, Antonio Gnoni, Nicola Di Renzo, Franco Dammacco, Pierfrancesco Tassone, Domenico Ribatti, Carlo Gambacorti-Passerini, Angelo Vacca

Blood (2008) 112 (4): 1346–1356.

https://doi.org/10.1182/blood-2007-10-116590

Published: 2008

Journal Articles

Constitutive expression of IL-12Rβ2 on human multiple myeloma cells delineates a novel therapeutic target

Irma Airoldi, Claudia Cocco, Nicola Giuliani, Marina Ferrarini, Simona Colla, Emanuela Ognio, Giuseppe Taverniti, Emma Di Carlo, Giovanna Cutrona, Vittorio Perfetti, Vittorio Rizzoli, Domenico Ribatti, Vito Pistoia

Blood (2008) 112 (3): 750–759.

https://doi.org/10.1182/blood-2008-02-139378

Published: 2008

Journal Articles

Epac1 activation and progenitor-cell homing

Domenico Ribatti

Blood (2008) 111 (5): 2501.

https://doi.org/10.1182/blood-2007-12-128629

Published: 2008

Journal Articles

Intense Reversal of Bone Marrow Angiogenesis after Consolidation Therapy with Alemtuzumab in Advanced Chronic Lymphocytic Leukemia.

Stefano Molica, MD, Marco Montillo, MD, Domenico Ribatti, MD, Rosanna Mirabelli, MD, Alessandra Tedeschi, MD, Francesca Ricci, MD, Silvio Veronese, MD, Angelo Vacca, MD, Enrica Morra, MD

Blood (2006) 108 (11): 4985.

https://doi.org/10.1182/blood.V108.11.4985.4985

Published: 2006

Journal Articles

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor

Helena Stabile, Stefania Mitola, Emanuela Moroni, Mirella Belleri, Stefania Nicoli, Daniela Coltrini, Francesco Peri, Antonello Pessi, Laura Orsatti, Fabio Talamo, Vincent Castronovo, David Waltregny, Franco Cotelli, Domenico Ribatti, Marco Presta

Blood (2006) 109 (5): 1834–1840.

https://doi.org/10.1182/blood-2006-06-032276

Published: 2006

Includes: Supplemental data

Journal Articles

Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma

Angelo Vacca, Claudio Scavelli, Guido Serini, Giulia Di Pietro, Teresa Cirulli, Francesca Merchionne, Domenico Ribatti, Federico Bussolino, Diego Guidolin, Giovanna Piaggio, Andrea Bacigalupo, Franco Dammacco

Blood (2006) 108 (5): 1661–1667.

https://doi.org/10.1182/blood-2006-04-014563

Published: 2006

Includes: Supplemental data

Journal Articles

Endothelial cells in the bone marrow of patients with multiple myeloma

Angelo Vacca, Roberto Ria, Fabrizio Semeraro, Francesca Merchionne, Mauro Coluccia, Angela Boccarelli, Claudio Scavelli, Beatrice Nico, Angela Gernone, Feliciana Battelli, Antonio Tabilio, Diego Guidolin, Maria Teresa Petrucci, Domenico Ribatti, Franco Dammacco

Blood (2003) 102 (9): 3340–3348.

https://doi.org/10.1182/blood-2003-04-1338

Published: 2003

Journal Articles

Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia

Stefano Molica, Angelo Vacca, Domenico Ribatti, Antonio Cuneo, Francesco Cavazzini, Domenico Levato, Gaetano Vitelli, Luigi Tucci, Aldo M. Roccaro, Franco Dammacco

Blood (2002) 100 (9): 3344–3351.

https://doi.org/10.1182/blood-2002-01-0084

Published: 2002

Journal Articles

Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its α receptor

Francesco De Marchis, Domenico Ribatti, Claudia Giampietri, Alessandro Lentini, Debora Faraone, Marco Scoccianti, Maurizio C. Capogrossi, Antonio Facchiano

Blood (2002) 99 (6): 2045–2053.

https://doi.org/10.1182/blood.V99.6.2045

Published: 2002

Journal Articles

I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo

Giovanni Bernardini, Gaia Spinetti, Domenico Ribatti, Grazia Camarda, Lucia Morbidelli, Marina Ziche, Angela Santoni, Maurizio C. Capogrossi, Monica Napolitano

Blood (2000) 96 (13): 4039–4045.

https://doi.org/10.1182/blood.V96.13.4039

Published: 2000

Journal Articles

Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine

Angelo Vacca, Monica Iurlaro, Domenico Ribatti, Monica Minischetti, Beatrice Nico, Roberto Ria, Antonio Pellegrino, Franco Dammacco

Blood (1999) 94 (12): 4143–4155.

https://doi.org/10.1182/blood.V94.12.4143

Published: 1999

Journal Articles

Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma

Angelo Vacca, Domenico Ribatti, Marco Presta, Monica Minischetti, Monica Iurlaro, Roberto Ria, Adriana Albini, Federico Bussolino, Franco Dammacco

Blood (1999) 93 (9): 3064–3073.

https://doi.org/10.1182/blood.V93.9.3064

Published: 1999

Journal Articles

Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo

Domenico Ribatti, Marco Presta, Angelo Vacca, Roberto Ria, Roberta Giuliani, Patrizia Dell’Era, Beatrice Nico, Luisa Roncali, Franco Dammacco

Blood (1999) 93 (8): 2627–2636.

https://doi.org/10.1182/blood.V93.8.2627

Published: 1999

NARROW

Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival

Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease

Soluble CX3CL1/Fractalkine Is a New Player in the Pro-Inflammatory Microenvironment of Multiple Myeloma Patients Related to Bone Marrow Plasma Cell Infiltration and Neo-Vascularization

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells

HOXB7 Is Critically Involved in Multiple Myeloma-Induced Angiogenic Switch.

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib

Constitutive expression of IL-12Rβ2 on human multiple myeloma cells delineates a novel therapeutic target

Epac1 activation and progenitor-cell homing

Intense Reversal of Bone Marrow Angiogenesis after Consolidation Therapy with Alemtuzumab in Advanced Chronic Lymphocytic Leukemia.

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor

Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma

Endothelial cells in the bone marrow of patients with multiple myeloma

Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia

Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its α receptor

I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo

Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine

Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma

Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only